BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9562346)

  • 1. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
    Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
    Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk.
    Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study.
    Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetologia; 2021 Oct; 64(10):2247-2257. PubMed ID: 34291312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.
    Hoppu S; Härkönen T; Ronkainen MS; Simell S; Hekkala A; Toivonen A; Ilonen J; Simell O; Knip M
    Clin Exp Immunol; 2006 Apr; 144(1):59-66. PubMed ID: 16542366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients.
    Asanghanwa M; Gorus FK; Weets I; der Auwera BV; Aminkeng F; Mbunwe E; Goubert P; Verhaeghen K; Sobngwi E; Wenzlau JM; Hutton JC; Pipeleers DG; Keymeulen B; Mbanya JC; van Schravendijk C
    Diabetes Res Clin Pract; 2014 Jan; 103(1):97-105. PubMed ID: 24332797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies.
    Lynch KF; Lee HS; Törn C; Vehik K; Krischer JP; Larsson HE; Haller MJ; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Hyöty H; Bonifacio E; Lernmark Å;
    J Autoimmun; 2018 Jan; 86():93-103. PubMed ID: 28941965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Diabetes From Childhood to Adulthood: The Role of Pancreatic Autoantibodies and HLA-DRB1 Genotype.
    Urrutia I; Martínez R; Calvo B; Saso-Jiménez L; González P; Fernández-Rubio E; Martín-Nieto A; Aguayo A; Rica I; Gaztambide S; Castano L
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1341-e1346. PubMed ID: 37207452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.
    Peakman M; Stevens EJ; Lohmann T; Narendran P; Dromey J; Alexander A; Tomlinson AJ; Trucco M; Gorga JC; Chicz RM
    J Clin Invest; 1999 Nov; 104(10):1449-57. PubMed ID: 10562307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering.
    Mistry S; Gouripeddi R; Raman V; Facelli JC
    Diabetologia; 2023 Mar; 66(3):520-534. PubMed ID: 36446887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children.
    Salami F; Tamura R; You L; Lernmark Å; Larsson HE; Lundgren M; Krischer J; Ziegler AG; Toppari J; Veijola R; Rewers M; Haller MJ; Hagopian W; Akolkar B; Törn C;
    Pediatr Diabetes; 2022 Dec; 23(8):1586-1593. PubMed ID: 36082496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia.
    Bonifacio E; Yu L; Williams AK; Eisenbarth GS; Bingley PJ; Marcovina SM; Adler K; Ziegler AG; Mueller PW; Schatz DA; Krischer JP; Steffes MW; Akolkar B
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3360-7. PubMed ID: 20444913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.
    Wyatt RC; Hagopian WA; Roep BO; Patel KA; Resnick B; Dobbs R; Hudson M; ; De Franco E; Ellard S; Flanagan SE; Hattersley AT; Oram RA; Johnson MB
    Diabetologia; 2022 Jul; 65(7):1179-1184. PubMed ID: 35501400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells.
    Xie H; Deng YJ; Notkins AL; Lan MS
    Clin Exp Immunol; 1998 Sep; 113(3):367-72. PubMed ID: 9737664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: The TEDDY Study.
    Li Q; Liu X; Yang J; Erlund I; Lernmark Å; Hagopian W; Rewers M; She JX; Toppari J; Ziegler AG; Akolkar B; Krischer JP;
    Diabetes; 2021 Jan; 70(1):282-292. PubMed ID: 33106256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Sudan.
    Ibrahim TAM; Govender D; Abdullah MA; Noble JA; Hussien MO; Lane JA; Mack SJ; Martin GGN; Atkinson MA; Wasserfall CH; Ogle GD
    Pediatr Diabetes; 2021 Aug; 22(5):749-757. PubMed ID: 33837995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.
    Krischer JP; Lynch KF; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2017 Sep; 40(9):1194-1202. PubMed ID: 28646072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes.
    Tojjar J; Cervin M; Hedlund E; Brahimi Q; Forsander G; Elding Larsson H; Ludvigsson J; Samuelsson U; Marcus C; Persson M; Carlsson A
    Diabetes Care; 2023 Nov; 46(11):1993-1996. PubMed ID: 37699205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.